Needle-Free Diabetes Care Market

Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both. Symptoms of Diabetes are hyperglycemic conditions, excessive excretion of urine, hunger, thirst, weight loss, fatigue and impaired vision. Diabetes is classified into Type 1 and Type 2 Diabetes.

Needle-Free Diabetes Care Market contains market size and forecasts of Needle-Free Diabetes Care in Global, including the following market information:

• Global Needle-Free Diabetes Care Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Needle-Free Diabetes Care market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Insulin Patches Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Needle-Free Diabetes Care include Antares Pharma, European Pharma Group, Johnson and Johnson, Injex UK, Echo Therapeutics and MannKind Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Needle-Free Diabetes Care companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Needle-Free Diabetes Care Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Needle-Free Diabetes Care Market Segment Percentages, by Type, 2021 (%)

• Insulin Patches
• Jet Injectors
• Insulin Pens
• Insulin Pumps
• Insulin Infuser

Global Needle-Free Diabetes Care Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Needle-Free Diabetes Care Market Segment Percentages, by Application, 2021 (%)

• Consumer
• Diagnostic Centers
• Hospitals and Clinics

Global Needle-Free Diabetes Care Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Needle-Free Diabetes Care Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Needle-Free Diabetes Care revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Needle-Free Diabetes Care revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Antares Pharma
• European Pharma Group
• Johnson and Johnson
• Injex UK
• Echo Therapeutics
• MannKind Corporation